Memogain is a Galantamine Pro-drug having Dramatically Reduced Adverse Effects and Enhanced Efficacy

Alfred Maelicke, Anja Hoeffle-Maas, Juergen Ludwig, Arno D.J. Maus, Marek Samochocki, Ulrich Jordis, Andreas K. E. Koepke

Journal of Molecular Neuroscience · 2009 · 73 citations · 5 references

Concepts

References

5